4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-18-008618
Senior Vice President, Finance sold 1,402 shares at $3.40 ($4,767)
- Senior Vice President, Finance acquired 3,334 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Blake John T Senior Vice President, Finance | 2018-02-07 | Option exercise | +3,334 | 3,334 | D | ||
| Blake John T Senior Vice President, Finance | 2018-02-08 | Sale | −1,402 | $3.40 | $4,767 | 1,932 | D |
| Derivatives | |||||||
| Blake John T Senior Vice President, Finance | 2018-02-06 | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | D | ||
| Blake John T Senior Vice President, Finance | 2018-02-07 | Option exercise · Restricted Stock Units | −3,334 | 6,666 | D | ||
| Open-market sales · 1,402 sh · avg $3.40 · $4,767 | |||||||
Loading xslF345X03/doc4.xml…